Skip to Content

Notice

Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is publishing a list of premarket approval applications (PMA's) that have been approved. This list is intended to inform the public of the availability of safety and effectiveness summaries of approved PMA's through the Internet and the agency's Dockets Management Branch.

ADDRESSES:

Submit a written request for copies of summaries of safety and effectiveness to the Dockets Management Branch (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Please cite the appropriate docket number listed in table 1 of this document when submitting a written request. See the SUPPLEMENTARY INFORMATION section for electronic access to the summaries of safety and effectiveness.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Thinh X. Nguyen, Center for Devices and Radiological Health (HFZ-402), Food and Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850, 301-594-2186.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

I. Background

In the Federal Register of January 30, 1998 (63 FR 4571), FDA published a final rule to revise §§ 814.44(d) and 814.45(d) (21 CFR 814.44(d) and 814.45(d)) to discontinue publication of individual PMA approvals and denials in the Federal Register. Instead, revised §§ 814.44(d) and 814.45(d) state that FDA will notify the public of PMA approvals and denials by posting them on FDA's home page at http://www.fda.gov on the Internet; by placing the summaries of safety and effectiveness on the Internet and in FDA's Dockets Management Branch; and by publishing in the Federal Register after each quarter a list of available safety and effectiveness summaries of approved PMA's and denials announced in that quarter.

FDA believes that this procedure expedites public notification of these actions because announcements can be placed on the Internet more quickly than they can be published in the Federal Register, and FDA believes that the Internet is accessible to more people than the Federal Register.

In accordance with section 515(d)(4) and (e)(2) of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 360e(d)(4) and (e)(2)), notification of an order approving, denying, or withdrawing approval of a PMA will continue to include a notice of opportunity to request review of the order under section 515(g) of the act. The 30-day period for requesting reconsideration of an FDA action under § 10.33(b) (21 CFR 10.33(b)) for notices announcing approval of a PMA begins on the day the notice is placed on the Internet. Section 10.33(b) provides that FDA may, for good cause, extend this 30-day period. Reconsideration of a denial or withdrawal of approval of a PMA may be sought only by the applicant; in these cases, the 30-day period will begin when the applicant is notified by FDA in writing of its decision.

The following is a list of approved PMA's for which summaries of safety and effectiveness were placed on the Internet in accordance with the procedure explained previously from October 1, 2000, through December 31, 2000. There were no denial actions during this period. The list provides the manufacturer's name, the product's generic name or the trade name, and the approval date.

Table 1.—List of Safety and Effectiveness Summaries for Approved PMA's Made Available October 1, 2000, Through December 31, 2000

PMA Number/Docket No.ApplicantTrade NameApproval Date
P970053/00M-1640Nidek Technologies, Inc.EC-5000 Excimer Laser SystemDecember 17, 1998
P970053(S1)/00M-1664Nidek Technologies, Inc.EC-5000 Excimer Laser System (PARK)September 29, 1999
P930034(S13)/00M-1591Summit TechnologiesSVS Apex Plus Excimer Laser WorkstationOctober 21, 1999
P990019/00M-1613DUSA Pharmaceuticals, Inc.BLU-U Light Photodynamic Therapy IlluminatorDecember 3, 1999
Start Printed Page 14391
P990027/00M-1597Bausch & Lomb Surgical, Inc.Technolas® 217 Excimer Laser SystemFebruary 23, 2000
P970043(S5)/00M-1593Autonomous Technologies Corp.LADAR Vision® Excimer Laser SystemMay 9, 2000
P990052/00M-1583Symphonix Devices, Inc.Vibrant P/Vibrant D Soundbridge SystemAugust 31, 2000
P980010/00M-1615Osteometer MediTech, Inc.DTU-One Ultrasound ScannerSeptember 19, 2000
P970043(S7)/00M-1612Autonomous Technologies Corp.LADAR Vision® Excimer Laser SystemSeptember 22, 2000
P990040/00M-1569Cordis Neurovascular, Inc.Trufill N-Butyl Cyanoacrylate Liquid Embolic SystemSeptember 25, 2000
P000014/00M-1658Ortho-Clinical Diagnostics, Inc.VITROS Immunodiagnostic Anti-HBS Reagent Pack and CalibratorsSeptember 29, 1999
P990046/00M-1570ATS Medical, Inc.ATS Open Pivot® Bileaflet Heart ValveOctober 13, 2000
N18286(S12)/00M-1616Pharmacia & Upjohn Co.Gelfoam® Sterile PowderOctober 16, 2000
P000015/00M-1659Cochlear Corp.Nucleus 24 Auditory Brainstem Implant (ABI) SystemOctober 20, 2000
P000018/00M-1649Novoste Corp.Beta-CathTM SystemNovember 3, 2000
P990036/00M-1650Cordis Corp.Cordis CheckmateTM SystemNovember 3, 2000
P990056/00M-1660Roche Diagnostics, Corp.Elecsys® Total PSA Immunoassay and CalsetNovember 22, 2000
P990081/00M-1661Ventana Medical Systems, Inc.PathwayTM HER 2November 28, 2000
P000027/00M-1683Roche Diagnostics Corp.Elecsys® Free PSA Immunoassay/Calset/CalcheckDecember 12, 2000
P980020/00M-1684Q Care International, LLCQ-103 Needle Management SystemsDecember 21, 2000

II. Electronic Access

Persons with access to the Internet may obtain the documents at http://www.fda.gov/​cdrh/​pmapage.html.

Start Signature

Dated: March 1, 2001.

Linda S. Kahan,

Deputy Director for Regulations Policy, Center for Devices and Radiological Health.

End Signature End Supplemental Information

[FR Doc. 01-5954 Filed 3-9-01; 8:45 am]

BILLING CODE 4160-01-F